progressive increase in the 7 days following the acute event 10 ; the increase was more evident in patients with cardiogenic shock. 11 In patients with AMI, the trend of TBARS plasma concentration was not influenced by thrombolytic treatment. 12 Moreover, in the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT), serum levels of TBARS were strongly predictive of cardiovascular events in patients with stable CAD. 13 Total antioxidant status (TAS) is an indicator of total plasma antioxidant systems (enzymatic and nonenzymatic) that may be induced by several factors. In normal subjects, TAS is reduced in smokers compared with nonsmokers 14 and in subjects with stable CAD. 4 Some authors observed a progressive decrease in TAS during the first week after AMI, 10 but in another study the same parameter examined in patients with AMI 15 was not different in comparison with normal controls. The TAS level was decreased in young survivors to AMI. 16 In animal models of myocardial infarction, a decrease in total antioxidant capacity was observed 17 ; when the same A lthough the role of oxidative stress in coronary artery disease (CAD) is well known, the studies regarding this aspect in acute myocardial infarction (AMI) are few and regarding juvenile AMI are even fewer. Some authors did not fìnd any difference between the lipid peroxidation in subjects with chronic CAD and stable angina in comparison with normal controls, 1-3 whereas others found a reduction in thiobarbituric acid reactive substance (TBARS) concentration in CAD subjects compared with normal controls. 4 Some studies demonstrated an increase in lipid peroxidation products in patients with chronic coronary heart disease. [5] [6] [7] [8] An increase in lipid peroxidation was observed in AMI, 9, 10 with a In 105 subjects (97 men and 8 women) aged <46 years (mean age 39.6 ± 5.5 years), with recent acute myocardial infarction (T1), thiobarbituric acid reactive substances and total antioxidant status were determined; NO production was evaluated by measuring the nitrite and nitrate (NOx) concentration. The patients with acute myocardial infarction were subdivided according to the main risk factors, number of risk factors, and extent of coronary lesions. The evaluation was repeated after 12 months (T2). In these subjects, thiobarbituric acid reactive substances and NOx were significantly increased and total antioxidant status was significantly decreased at T1. In single risk factor, only NO metabolites were significantly lower in acute myocardial infarction subjects who smoke than in subjects who do not. Subdividing the subjects according to the number of risk factors and number of stenosed coronary vessels, there were no significant differences between the subgroups. At T2, thiobarbituric acid reactive substances and NOx were decreased and total antioxidant status was increased, but all parameters were still altered.
Keywords: acute myocardial infarction in young people; oxidative status; lipid peroxidation; nitric oxide animals were treated in advance with ascorbic acid, TAS was found markedly increased.
Vassalle et al 18 demonstrated an increase in TBARS and a decrease in TAS in patients with angiographically proven CAD, and both parameters were significantly related to the extent of coronary lesions.
Sporadic data are available on NO oxidative products during acute coronary syndrome. Unlike the behavior during the stable phase of CAD in which there is a decrease in nitrite and nitrate (NOx) because of endothelial dysfunction, 19 during the acute stage of AMI, there is an increase in inducible nitric oxide synthase (iNOS) activity and consequently in NO oxidative products, which is a reaction to the high oxidative stress during this clinical condition. 20 In animal models, following ligation of left anterior descending coronary artery, a NOx increase was observed that reached a peak after 3 days. 21 The same research also showed a close correlation between NOx and iNOS activity and an inhibitory action carried out by S-methylisothiourea; the latter is one of the iNOS inhibitors. 22 The NOx concentration was also determined in arterial and venous coronary blood in a small group of patients with anterior myocardial infarction 24, 48, and 72 hours after the acute event. 23 The peak of NOx elevation occurred 2 and 3 days after the onset of symptoms, suggesting that the NOx increase correlated with the iNOS activation induced by cytokines. Recently, the same datum has been demonstrated in a large group of patients with AMI. 24 The aim of this research was to examine some parameters reflecting the oxidative status in young patients with AMI at the initial stage and 12 months later. This study is a part of the scientific project identified as "Sicilian Study on Juvenile Myocardial Infarction."
Subjects and Methods
In this study, 105 subjects (97 men and 8 women) aged <46 years, with recent AMI were studied. The mean age was 39.6 ± 5.5 years (range . The time interval between AMI onset and the examination was 13 ± 7 days. Regarding the main risk factors, 49% had family history of CAD, 83% were cigarette smokers or ex-smokers; hypercholesterolemia was present in 51%, diabetes mellitus in 12%, and essential hypertension in 24%. The AMI subjects were subdivided according to the number of risk factors into 3 groups: 38 patients had 0 to 1 risk factor, 35 had 2 risk factors, and 32 had 3 to 5 risk factors.
Coronary angiography was performed in 92 patients and the subjects were subdivided into 3 groups on the basis of the extent of coronary lesions: 21 patients showed no lesions that were considered significant, 1-vessel disease was present in 41 patients, and 2-or 3-vessel disease was present in 30 patients.
An echocardiographic evaluation was performed in each patient at hospital discharge, and ejection fraction was calculated as (end-diastolic volume − end-systolic volume)/end-diastolic volume. In the whole, AMI group ejection fraction was 55.3 ± 8.2% (range 37%-73%).
The control group included 51 subjects (39 men and 12 women; mean age = 36.2 ± 7.8 years) without signs of acute or chronic vascular disease (history, physical examination, laboratory and instrumental tests).
The study was approved by the Ethical Committee and each subject gave informed consent.
The parameters evaluated were the plasma lipid peroxidation, the TAS, and the NO production.
Plasma Lipid Peroxidation
The oxidation of polyunsaturated fatty acids was evaluated in plasma by detection of the TBARS, generated by peroxidative processes, which include lipid peroxides and malondialdehyde. The evaluation of TBARS was made by fluorimetry, using 1,1,3,3tetramethoxypropane as standard. 25 
Total Antioxidant Status
Total antioxidant status was obtained using an assay kit (Calbiochem, La Jolla, Calif), which relies on the ability of plasma antioxidant substances to inhibit the oxidation of 2,2′-azino-bis(3-ethylbenzthiazoline sulfonic acid [ABTS]) to the radical cation ABTS •+ by a peroxidase. 26 The radical concentration was measured using spectrophotometry.
NO Production
The NO production was evaluated by a micromethod, which measures the concentration of the end products of NO in vivo: NOx. At first, nitrate was converted into nitrite by a nitrate reductase, then nitrite was measured using spectrophotometry after addition of Griess reagent (Nitrate/Nitrite colorimetric assay kit; Cayman Chemical Company, Ann Arbor, Mich). 27
Statistical Analysis
Data were expressed as means ± SD; the difference between control subjects and AMI subjects was evaluated according to the Student t test for unpaired data. The statistical difference between control subjects and AMI subjects, subdivided according to the presence or absence of a single risk factor, the number of cardiovascular risk factors, and the number of stenosed coronary vessels, was estimated according to the 1-way analysis of variance (ANOVA) model; then the Bonferroni multiple t test was performed to compare every pair of subgroups. The difference between AMI subjects at T1 and T2 was evaluated according to the Student t test for paired data.
For all the statistical tests, the null hypothesis was rejected for P values less than .05. The correlation between each parameter and the ejection fraction was evaluated according to linear regression.
Results
At the initial evaluation in AMI subjects, TBARS and NOx were significantly increased and TAS was significantly decreased in comparison with control subjects (Table 1) .
Considering the main risk factors (family history, smoking, hypercholesterolemia, diabetes mellitus, essential hypertension), the patients with AMI were subdivided into pairs of subgroups with and without each risk factor. Subdividing the patients into smokers and nonsmokers revealed that NO metabolites were significantly lower in nonsmoker than in smoker AMI subjects ( Table 2 ). We did not observe significant differences in TBARS and TAS between any pair of subgroups.
Subdividing AMI subjects according to the number of risk factors revealed no significant differences between the subgroups (Table 3) . Similarly, subdividing AMI subjects according to the number of stenosed coronary vessels, there were no significant differences between the subgroups (Table 4 ).
In the whole group of AMI subjects, the ejection fraction was not related to the oxidative parameters or NO metabolites. The ejection fraction was not related to these parameters both in the subgroups according to the number of risk factors and in the subgroups according to the extent of coronary lesions. In the 55 patients with AMI who were reevaluated after 1 year (T2), TBARS and NOx were decreased and TAS was increased compared with T1, but all parameters were still altered in comparison with control subjects ( Table 5 ).
Discussion
The initial stage of AMI showed an increase in lipid peroxidation and NO metabolites and a decrease in the antioxidant activity. The possible influence of the main risk factors on these parameters was evaluated, and only smoking gave significant results. Patients with AMI compared with the patients who smoke had in fact a reduced mean value of NO metabolites than nonsmoker patients with AMI, even if in this group of patients with AMI the latter represented the absolute majority (83%).
In the whole group of patients with AMI, the correlation between each parameter and the ejection fraction was studied without obtaining significant results; other authors demonstrated a relationship between some parameters reflecting oxidative stress and left ventricular volume but not with the ejection fraction. 28 This study was carried out making a double subdivision regarding either the total number of risk factors or the extent of coronary disease. Neither the subdivision based on risk factors nor the one based on the extent of coronary disease seemed to influence the behavior of the considered parameters, although in patients with AMI with the highest number of risk factors (>2) and with the widest coronary disease (2-3 blood vessels) a greater increase of NO metabolites was observed. The behavior of NO metabolites, as it has been observed in experimental models, must be ascribed to their macrophagical overproduction because of the activation of iNOS induced by cytokines. 21 The correlation between each parameter and the ejection fraction was not significant also when patients with AMI were subdivided for the number of risk factors and for the extent of coronary disease. From this approach some indications might be expected, considering that the increase of NOx in animal models seems to have a negative inotropic effect. 20, 21, 29 However, the unexpected datum regards the behavior of the same parameters examined 12 months after the acute event. Even if a significant reduction 424 Clinical and Applied Thrombosis/Hemostasis / Vol. 14, No. 4, October 2008 of lipid peroxidation and NO metabolite concentration and an increase of total antioxidant capacity are observed in comparison with the initial stage, nevertheless the mean of each parameter remains statistically different in comparison with normal controls. This datum must be underlined especially if we consider that many AMI subjects have given up smoking and that all have received a therapeutic plan including, in addition to angiotensin converting enzyme inhibitors and antiaggregating agents, statins that play an antioxidant activity. [30] [31] [32] [33] [34] Among the parameters reflecting the oxidative stress, the datum regarding the NOx deserves a particular remark because its behavior at the initial stage can be attributed to the iNOS increased activity of activated macrophages, but it is difficult to ascribe this mechanism to oxidative status after 12 months, considering that the NO macrophagical production is mainly induced by cytokines released during the acute phase. It is not possible to exclude that all these aspects may be related to the high prevalence of inflammatory gene polymorphism demonstrated in these young subjects with AMI. [35] [36] [37] [38] [39] The persistence of an impaired oxidative stress 12 months after AMI requires 2 different considerations: first, the use of antioxidant therapy after AMI may be advisable [40] [41] [42] [43] ; moreover, the altered oxidative status observed much later after AMI may be present also before AMI. Regarding this latter aspect, our project of reevaluating the same AMI subjects 2 years or even later after AMI may give further information. 
